http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3787324-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
filingDate 1971-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1974-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d5a7d90649f5a0a3e6b2cedb53d6250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdd04fe2fef9f245089715a09a7d8f79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a05fefd2c3848b854d47d3ef44afa8c
publicationDate 1974-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3787324-A
titleOfInvention 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
abstract COMPOUNDS HAVING THE FOLLOWING STRUCTURAL FORMULA ARE DISCLOSED: 3-((4-R2,5-R3-2-ISOXAZOLIN-3-YL)-NH-CO-),1,1-DI(O=),2-R1, 4-(HO-)-2H-1,2-BENZOTHIAZINE WHEREIN R1 IS HYDROGEN OR METHYL AND R2, AND R3 ARE HYDROGEN OR ALKYL. THESE COMPOUNDS ARE USEFUL AS ANTI-INFLAMMATORY AGENTS, ANTIPYRETICS, ANALGESICS.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5321017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2154585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4829062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3957772-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4656265-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5308839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4551452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3987038-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010172960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0208404-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008044095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5459135-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009238763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9872846-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11541029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9371284-B2
priorityDate 1971-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID34205
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID34205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID172266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409757648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129129103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1810216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406963788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208023
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID172266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20566489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66172

Total number of triples: 50.